Small Molecules Drive Big Improvements in Immuno-Oncology Therapies.

ABSTRACT: Immuno-oncology therapies have the potential to revolutionize the armamentarium of available cancer treatments. To further improve clinical response rates, researchers are looking for novel combination regimens, with checkpoint blockade being used as a backbone of the treatment. This Review highlights the significance of small molecules in this approach, which holds promise to provide increased benefit to cancer patients.

SUBMITTER: Huck BR 

PROVIDER: S-EPMC5900885 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature